Clinical Trials Directory

Trials / Conditions / Glycogen Storage Disease Type III

Glycogen Storage Disease Type III

8 registered clinical trials studyying Glycogen Storage Disease Type III — 1 currently recruiting.

StatusTrialSponsorPhase
TerminatedClinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glyco
NCT05196165
Ultragenyx Pharmaceutical Inc—
TerminatedSafety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD II
NCT04990388
Ultragenyx Pharmaceutical IncPhase 1 / Phase 2
CompletedStudy to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III
NCT04574830
Ultragenyx Pharmaceutical Inc—
WithdrawnBiomarker for Glycogen Storage Diseases (BioGlycogen)
NCT02385162
CENTOGENE GmbH Rostock—
UnknownFat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy
NCT02635269
Rigshospitalet, DenmarkN/A
CompletedEnergy Supplements to Improve Exercise Tolerance in Metabolic Myopathies
NCT02448667
Rigshospitalet, DenmarkN/A
CompletedSleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Corns
NCT02054832
John Mitchell—
RecruitingFrench Observatory for Patients with Type 3 Glycogenosis
NCT06616545
Institut de Myologie, France—